Key Market Indicators
Iceland's medical product expenditure is projected to reach €172 million by 2028, up from approximately €152 million in 2023. This marks an annual growth rate of 2%. Since the turn of the century, Iceland's demand for medical products has increased at an annual rate of 4.8%. However, in the latest rankings for 2023, Iceland held the 31st position, having been overtaken by Malta, which also recorded €152 million in expenditures. Leading the rankings were France, the United Kingdom, and Poland, occupying the second, third, and fourth positions respectively.